1-20 of 30
Laura Rosiñol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pattern of Relapse and Progression After Autologous Stem-Cell Transplantation As Upfront Treatment for Multiple Myeloma

Carlos Fernández de Larrea, Raquel Jiménez, Laura Rosiñol, MD, Eva Giné, Natalia Tovar, María Teresa Cibeira, Francesc Fernandez-Avilés, Carmen Martinez, Montserrat Rovira, Joan Blade, MD
Journal: Blood
Blood (2012) 120 (21): 3987.
https://doi.org/10.1182/blood.V120.21.3987.3987
Published: 2012
Journal Articles

Characterization and Prognostic Impact of Oligoclonal Humoral Response in Patients with Multiple Myeloma After Autologous Stem-Cell Transplantation: Long-Term Results From a Single Institution

Natalia Tovar, Carlos Fernández de Larrea, Juan I. Aróstegui, María Teresa Cibeira, Laura Rosiñol, MD, Montserrat Rovira, Montserrat Elena, Xavier Filella, Jordi Yagüe, Joan Blade, MD
Journal: Blood
Blood (2012) 120 (21): 3948.
https://doi.org/10.1182/blood.V120.21.3948.3948
Published: 2012
Journal Articles

Whole Bone Marrow (BM) Immunophenotypic Profiling for the Identification of Newly Diagnosed Symptomatic Multiple Myeloma (MM) Patients with an MGUS-Like Signature Associated with Long-Term Disease Control (LTDC)

Bruno Paiva, María-Belén Vidriales, Jose J. Perez, María-Angeles Montalbán, Norma Gutierrez, Laura Rosiñol, MD, Joaquín Martínez-López, MD, María-Victoria Mateos, MD, PhD, Lourdes Cordon, Albert Oriol, Maria Jose Terol, MD, Maria Asuncion Echeveste, Raquel Paz, Felipe de Arriba, Luis Palomera, MD, Javier De La Rubia, MD, Joaquín Díaz-Mediavilla, Anna Sureda, MD, PhD, Ana Gorosquieta, Adrian Alegre, Alejandro Martín, Alberto Orfao, Juan-Jose Lahuerta, MD, Joan Blade, MD, Jesus F. San Miguel, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3949.
https://doi.org/10.1182/blood.V120.21.3949.3949
Published: 2012
Journal Articles

Impact of Single Nucleotide Polymorphisms in Genes Involved in DNA Repair and Drug Metabolism On Survival After Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.

Carlos Fernández de Larrea, Alfons Navarro, PhD, Natalia Tovar, Fabiola Pedrosa, Tania Díaz, PhD, María Teresa Cibeira, Laura Magnano, Laura Rosiñol, MD, Montserrat Rovira, María Rozman, Mariano Monzó, MD, PhD, Joan Blade, MD
Journal: Blood
Blood (2012) 120 (21): 2934.
https://doi.org/10.1182/blood.V120.21.2934.2934
Published: 2012
Journal Articles

Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies

Michele Cavo, MD, Pieter Sonneveld, MD, Philippe Moreau, MD, Joan Bladè, MD, Hartmut Goldschmidt, MD, Jesús F San Miguel, MD, Michel Attal, MD, Hervé Avet-Loiseau, MD, PhD, Wolgang Igor Blau, MD, Thierry Facon, MD, Norma Gutierrez, Jean-Luc Harousseau, MD, Bronno van der Holt, Juan Jose Lahuerta, MD, Henk Lokhorst, MD, Gerald Marit, MD, Maria Luisa Martin, PhD, Giulia Marzocchi, PhD, Antonio Palumbo, MD, Francesca Patriarca, MD, Maria Teresa Petrucci, MD, Laura Rosiñol, MD, Hans Salwender, MD, Carolina Terragna, PhD
Journal: Blood
Blood (2012) 120 (21): 749.
https://doi.org/10.1182/blood.V120.21.749.749
Published: 2012
Journal Articles

High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Bruno Paiva, Norma C. Gutierrez, Laura Rosiñol, MD, María-Belén Vidriales, María-Angeles Montalbán, Joaquín Martínez-López, MD, Maria Victoria Mateos, María Teresa Cibeira, Lourdes Courdón, Albert Oriol, María José Terol, MD, PhD, Maria-Asuncion Echebeste, Raquel de Paz, Felipe de Arriba, Luis Palomera, Javier De La Rubia, Joaquín Díaz-Mediavilla, Anna Sureda, MD, PhD, Ana Gorosquieta, Adrian Alegre, Alejandro Martín, Miguel T. Hernandez, Juan José Lahuerta, Joan Blade, Jesus F. San Miguel, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 630.
https://doi.org/10.1182/blood.V118.21.630.630
Published: 2011
Journal Articles

Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial

Meletios Athanasios Dimopoulos, MD, Sundar Jagannath, MD, Sung-Soo Yoon, MD, PhD, David S. Siegel, MD, PhD, Sagar Lonial, MD, Roman Hajek, MD, PhD, Thierry Facon, MD, Laura Rosiñol, MD, Hilary Anne Blacklock, MD, Hartmut Goldschmidt, MD, Vania Hungria, MD, Andrew Spencer, MD, Antonio Palumbo, MD, Donna E. Reece, MD, FRCPC, Thorsten Graef, MD, PhD, Jennifer Houp, Linda Sun, PhD, Joseph E. Eid, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2011) 118 (21): 811.
https://doi.org/10.1182/blood.V118.21.811.811
Published: 2011
Journal Articles

Smoldering Multiple Myeloma (SMM) At High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) As Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

María-Victoria Mateos, MD, PhD, Lucía López-Corral, Miguel Hernández, Pilar Giraldo, MD, PhD, Javier De La Rubia, Felipe de Arriba, Laura Rosiñol, MD, Juan José Lahuerta, Luis Palomera, Joan Bargay, Albert Oriol, Felipe Prosper, MD, Javier López, Eduardo Olavarría, MD, Maria Luz Martino, MD, Ana-Isabel Teruel, Jose Mariano Hernández, Graça Esteves, Jose Mario JS Mariz, MD, Fernando Leal-da-Costa, MD, Adrian Alegre, MD, Jose-Luis Guzman, Ana López de la Guía, Jose Baquero, Nuria Quintana, Jose Luis García, Jesðs F. San Miguel
Journal: Blood
Blood (2011) 118 (21): 991.
https://doi.org/10.1182/blood.V118.21.991.991
Published: 2011
Journal Articles

Myelodysplasia-Associated Immunophenotypic Abnormalities of Bone Marrow (BM) Cells in Multiple Myeloma (MM): Are They Present At Diagnosis or Can Be Induced by Lenalidomide?

Sergio Matarraz, Bruno Paiva, Maria Victoria Mateos, María Diez-Campelo, MD, PhD, Estefania Perez, María-Belén Vidriales, Lucía López-Corral, Pilar Giraldo, Miguel T. Hernandez, Felipe de Arriba, Javier De La Rubia, Joan Bargay, Fernando Leal da Costa, Graça Esteves, Juan José Lahuerta, Laura Rosiñol, MD, Joan Blade, Jesus F. San Miguel, MD, PhD, Alberto Orfao, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 5066.
https://doi.org/10.1182/blood.V118.21.5066.5066
Published: 2011
Journal Articles

Under Scope of the Current Redefinition Process of Optimal Response in Multiple Myeloma: Assesment of Molecular Response by Fluorescent PCR of Ig Genes Has Similar Applicability and Prognosis Impact to Immunophenotypic Response. (A GEM/PETHEMA study),

Elena Fernandez Redondo, Joaquin Martinez-Lopez, Ramón García-Sanz, María-Angeles Montalbán, Pilar Martinez-Sanchez, Bruno Paiva, Maria-Victoria Mateos, MD, PhD, Laura Rosiñol, MD, Maria Luisa Martin, Rosa M. Ayala, MD, PhD, Rafael Martinez, MD, Javier Lopez, Adrian Alegre, Joan Besalduch, Joan Bargay, MT Hernandez, Maria Eugenia Sarasquete, P. sanchez-Godoy, Manuel Callis, MD, Manuela Fernandez, Joan Blade, Jesus F. San Miguel, MD, PhD, Juan José Lahuerta
Journal: Blood
Blood (2011) 118 (21): 3951.
https://doi.org/10.1182/blood.V118.21.3951.3951
Published: 2011
Journal Articles

A Phase III PETHEMA/GEM Randomized Trial of Postransplant (ASCT) Maintenance in Multiple Myeloma: Superiority of Bortezomib/Thalidomide Compared with Thalidomide and Alfa-2b Interferon,

Laura Rosiñol, MD, María Teresa Cibeira, Maria Victoria Mateos, Joaquin Martinez, MD, Albert Oriol, Ana Isabel Teruel, Dolores Hernández, Javier López, MD, Javier de la Rubia, Miquel Granell, MD, Juan Besalduch, MD, PhD, Luis Palomera, Yolanda González, MD, Maria Asunción Etxebeste, MD, Joaquín Díaz-Mediavilla, Miguel T Hernández, MD, Felipe de Arriba, Adrian Alegre, Juan José Lahuerta, Jesus F San Miguel, MD PhD, Joan Blade
Journal: Blood
Blood (2011) 118 (21): 3962.
https://doi.org/10.1182/blood.V118.21.3962.3962
Published: 2011
Journal Articles

Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients,

Bruno Paiva, Norma C. Gutierrez, Xi Chen, María-Belén Vidriales, María-Angeles Montalbán, Laura Rosiñol, MD, Albert Oriol, Joaquín Martínez-López, MD, Maria Victoria Mateos, Lucía López-Corral, Elena Díaz-Rodríguez, Jose J. Perez, Elena Fernandez-Redondo, Felipe de Arriba, Luis Palomera, Enrique Bengoechea, María José Terol, MD, PhD, Raquel de Paz, Alejandro Martín, Jose Hernández, Alberto Orfao, MD, PhD, Juan José Lahuerta, Joan Blade, Atanasio Pandiella, Jesus F. San Miguel, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3936.
https://doi.org/10.1182/blood.V118.21.3936.3936
Published: 2011
Journal Articles

Multiparameter Flow Cytometry (MFC) Evaluation of Plasma Cell (PC) DNA Ploidy Status and Proliferative Rate in 595 Multiple Myeloma (MM) Patients (pts) Included in the Spanish GEM2000 and GEM2005<65years Trials: Clinical Value and Biological Insights,

Bruno Paiva, María-Belén Vidriales, María-Angeles Montalbán, Jose J. Perez, Norma C. Gutierrez, Laura Rosiñol, MD, Joaquín Martínez-López, MD, Maria Victoria Mateos, Lourdes Courdón, Albert Oriol, María José Terol, MD, PhD, Maria Asunción Etxebeste, Raquel de Paz, Felipe de Arriba, Luis Palomera, Javier De La Rubia, Joaquín Díaz-Mediavilla, Anna Sureda, MD, PhD, Ana Gorosquieta, Adrian Alegre, Alejandro Martín, Miguel T. Hernandez, Juan José Lahuerta, Joan Blade, Jesús F San Miguel, MD PhD
Journal: Blood
Blood (2011) 118 (21): 3938.
https://doi.org/10.1182/blood.V118.21.3938.3938
Published: 2011
Journal Articles

Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients,

Bruno Paiva, Maria Victoria Mateos, Lucía López-Corral, María-Belén Vidriales, Miguel T. Hernandez, Joan Bargay, Felipe de Arriba, Javier De La Rubia, Ana-Isabel Teruel, Pilar Giraldo, Laura Rosiñol, MD, Felipe Prosper, MD, Albert Oriol, Jose Hernández, Graça Esteves, Fernando Leal da Costa, Juan José Lahuerta, Joan Blade, Jesus F. San Miguel, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3944.
https://doi.org/10.1182/blood.V118.21.3944.3944
Published: 2011
Journal Articles

Impact of Single Nucleotide Polymorphisms in Genes Involved in miRNA Network on Survival and Progression After Autologous Stem Cell Transplantation in Patients with Multiple Myeloma,

Carlos Fernández de Larrea, Alfons Navarro, PhD, Tania Díaz, PhD, María Teresa Cibeira, Rut Tejero, Natalia Tovar, Gerardo Ferrer, Msc, Laura Rosiñol, MD, Montserrat Rovira, María Rozman, Mariano Monzó, MD, PhD, Joan Blade
Journal: Blood
Blood (2011) 118 (21): 3945.
https://doi.org/10.1182/blood.V118.21.3945.3945
Published: 2011
Journal Articles

Impact of Global and Gene-Specific DNA Methylation Pattern in Relapsed Multiple Myeloma Patients Treated with Bortezomib

Carlos Fernández de Larrea, Beatriz Martin-Antonio, María Teresa Cibeira, Alfons Navarro, PhD, Natalia Tovar, Tania Díaz, PhD, Laura Rosiñol, MD, Mariano Monzó, MD, PhD, Alvaro Urbano-Izpizua, Joan Blade
Journal: Blood
Blood (2011) 118 (21): 132.
https://doi.org/10.1182/blood.V118.21.132.132
Published: 2011
Journal Articles

Phase I/I Clinical Trial for the Evaluation of Bortezomib within the Reduced Intensity Conditioning Regimen (RIC) and Post-Allogeneic Transplantation As Gvhd Prophylaxis Among High-Risk Myeloma Patients. EudraCT: 2005–004858-27

Jose Antonio Perez-Simón, Sr., MD, PhD, Teresa Caballero-Velazquez, Cristina Encinas, Cristina Castilla-Llorente, Rodrigo Martino, MD, PhD, Laura Rosiñol, MD, Antonia Sampol, MD, Dolores Caballero, MD, David Serrano, Inmaculada Heras, Jesus F San Miguel
Journal: Blood
Blood (2011) 118 (21): 3025.
https://doi.org/10.1182/blood.V118.21.3025.3025
Published: 2011
Journal Articles

Impact on Response and Survival of DNA Repair Single Nucleotide Polymorphisms In Relapsed or Refractory Multiple Myeloma Patients Treated with Thalidomide

Carlos Fernández de Larrea, María Teresa Cibeira, Alfons Navarro, Tania Díaz, Dolors Fuster, Natalia Tovar, Laura Rosiñol, Mariano Monzó, Joan Blade
Journal: Blood
Blood (2010) 116 (21): 4041.
https://doi.org/10.1182/blood.V116.21.4041.4041
Published: 2010
Journal Articles

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Bruno Paiva, Lucía López-Corral, María-Belén Vidriales, Luis Ignacio Sánchez Abarca, Miguel T. Hernandez, Joan Bargay, Javier De La Rubia, Pilar Giraldo, Ana-Isabel Teruel, Laura Rosiñol, Albert Oriol, Jose Hernández, Felipe de Arriba, Graça Esteves, Jose Antonio Pérez Simón, María-Victoria Mateos, Jesus F San Miguel
Journal: Blood
Blood (2010) 116 (21): 1906.
https://doi.org/10.1182/blood.V116.21.1906.1906
Published: 2010
Journal Articles

Smoldering Multiple Myeloma (SMM) at High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) as Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

María-Victoria Mateos, Lucía López-Corral, Miguel Hernández, Pilar Giraldo, PhD, Javier De La Rubia, Felipe de Arriba, Laura Rosiñol, Juan-Jose Lahuerta, Luis Palomera, Joan Bargay, Albert Oriol, Felipe Prosper, MD, Jose Garcia-Laraña, Eduardo Olavarría, Maria Luz Martino, Ana-Isabel Teruel, Jose Hernández, Graça Esteves, Jose Mario Mariz, Fernando Leal-da-Costa, MD, Adrian Alegre, Jose-Luis Guzman, Ana López de la Guía, Nuria Quintana, Jose Baquero, Jose Luis García, Jesús F. San Miguel, Sr, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1935.
https://doi.org/10.1182/blood.V116.21.1935.1935
Published: 2010